Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxic myopathies

K K George1, R Pourmand

  • 1Department of Neurology, Indiana University Medical Center, Indianapolis, Indiana 46202, USA.

Neurologic Clinics
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Toxic myopathies, muscle damage from drugs or toxins, require prompt recognition. Understanding causes, symptoms, and risk factors is crucial for effective treatment, especially in vulnerable patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Message from the editor.

Journal of clinical neuromuscular disease·2008
Same author

Evaluation of a patient presenting with foot drop.

Journal of clinical neuromuscular disease·2008
Same author

Chloroqutne myopathy.

Journal of clinical neuromuscular disease·2008
Same author

Clinical Neuromuscular Highlights of the 46th Annual Scientific Meeting of the American Association of Electrodiagnosis Medicine (AAEM) Vancouver, BC, Canada October 6-9, 1999.

Journal of clinical neuromuscular disease·2008
Same author

Evaluation of a patient presenting with progressive dysarthria and fasciculations of tongue and limb muscles.

Journal of clinical neuromuscular disease·2008
Same author

52nd annual meeting of the American Academy of Neurology, San Diego, California, april 29-may 6, 2000, and the 47th annual scientific meeting of the American Association of Electrodiagnostic Medicine, Philadelphia, Pennsylvania, september 13-16, 2000.

Journal of clinical neuromuscular disease·2008
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Area of Science:

  • Neurology
  • Toxicology
  • Pathology

Background:

  • Myopathies can arise from prescribed medications, illicit drug use, and environmental toxins.
  • Recognizing toxic myopathies is vital for timely diagnosis and management.

Purpose of the Study:

  • To provide a comprehensive overview of drug- and toxin-induced myopathies.
  • To detail clinical, laboratory, histological, and mechanistic aspects of toxic myopathies.

Main Methods:

  • Literature review of compounds causing myopathy.
  • Analysis of clinical presentations and diagnostic features.
  • Discussion of pathological mechanisms and risk factors.

Main Results:

  • Identified various agents causing toxic myopathy.

Related Experiment Videos

  • Described characteristic clinical and laboratory findings.
  • Highlighted histological patterns and proposed mechanisms of muscle damage.

    • Conclusions:

    • Early identification of toxic myopathies prevents unnecessary investigations and treatment delays.
    • Essential for managing critically ill patients and those with pre-existing neuromuscular conditions.